CO-GESIC Drug Patent Profile
When do Co-gesic patents expire, and when can generic versions of Co-gesic launch?
Co-gesic is a drug marketed by Cent Pharms and Ucb Inc and is included in two NDAs.
The generic ingredient in CO-GESIC is acetaminophen; hydrocodone bitartrate. There is one drug master file entry for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CO-GESIC?
- What are the global sales for CO-GESIC?
- What is Average Wholesale Price for CO-GESIC?
Summary for CO-GESIC
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 661 |
| DailyMed Link: | CO-GESIC at DailyMed |
US Patents and Regulatory Information for CO-GESIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cent Pharms | CO-GESIC | acetaminophen; hydrocodone bitartrate | CAPSULE;ORAL | 089360-001 | Mar 2, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ucb Inc | CO-GESIC | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 087757-001 | May 3, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
